immunity therapy

June 21, 2024

Identification of RFC4 as a potential biomarker for pan‐cancer involving prognosis, tumour immune microenvironment and drugs

Abstract RFC4 is required for DNA polymerase δ and DNA polymerase ε to initiate DNA template expansion. Downregulated RFC4 inhibits…

March 9, 2023

The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma

Abstract Background: C15orf48 was recently identified as an inflammatory response-related gene; however there is limited information on its function in…